Sample Marker Measurement into the sub-picogram/ml region
Sample Marker Measurement into the sub-picogram/ml region
Proteomics (Multiplex Immunoassay)
Our service is provided across multiple therapeutic areas, and is fully customisable.
Our high sensitivity technology provides multiplexing of marker measurement by custom or fixed marker panels.
Our technology is successful in delivering surrogate demonstration of clinical efficacy and mechanism of action, complimented by our multiplex gene expression through targeted RNA-Seq.
-
One of our core specialities is providing tailored customization of biomarkers.
We optimize your biomarker strategy to unlock its full potential in demonstrating mechanism of action. We understand that every project is unique and our experienced team works closely with you to identify the most relevant biomarkers for your specific goals. By leveraging cutting-edge technologies, patented and unique to Aeirtec, we enable you to design a biomarker panel that aligns with your research objectives and candidate progression to the next phase.
-
Integration of Aeirtec's unique assay biochemistry technology and patented standard curve analysis equations enable Aeirtec to accurately extend sample marker measurement into the sub-picogram/ml region.
-
We have 5 color fluorescent imaging systems linked to image analysis packages for quantitation in frozen and formalin-fixed samples section
-
As part of our immune and inflammation pharmacology expertise, we conduct monitoring of immune and inflammatory cell behavior with flow cytometry and ELISPOT
-
We recognize the critical role that data analysis plays in unravelling the complexities of biomarkers. Our bio-statisticians possess expertise in analyzing large datasets, employing advanced statistical methodologies to extract clinical and molecular biomarker-derived candidate characterization; facilitating pipeline progression.
We harness the power of simultaneous multiple biomarker measurements coupled with multivariate analysis. This ensures that your chosen biomarkers are accurately evaluated and interpreted to facilitate informed decision-making and candidate progression.
-
Aeirtec works beyond the data. We understand that accurate data interpretation is vital for demonstrating mechanism of action.
Our team of skilled professionals examines the data in the context of the therapeutic application, offering interpretation that facilitates evidence-based candidate profiling and progression to the next phase.
Our service is conducted under the principles of GLP and ISO17025:2017.
Clinical Study Design/ Decision on Marker Panel
Optional Service Extras
Standard Service
Clinical Study Design/ Decision on Marker Panel
Use of Sponsor Choice of Multiplex Panel
Study Sample Batch Delivery to UK
Study Sample Batch Delivery to UK
Multiplex Sample Analysis at Aeirtec
Report with Data
*Our service is conducted according to the principles of GLP and ISO 17025:2017 compliance in conjunction with internal and external independent Quality Assurance. (Recent external audit results available).
Our panel assays are validated prior to sample analysis.
Each marker assay of samples is accompanied by measurements of lower and upper limits of quantification (LLOQ and ULOQ) derived from calibration curves conducted, crucially, at the time of sample analysis.
Our Service Expertise
-
Patented Technology
High sensitivity multiplexing activity at Aeirtec
-
About Us
Examples of our work and expertise
-
Customization of Markers
Clinical condition specific marker panel customization
-
Multivariate Biostatistics
Better data interpretation with multivariate biostatistics
